Novan Therapeutics Obtains $50,000,000 New Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4c8879da-b9ad-4dd7-bff9-a224ee0d26b6 -
Date
3/31/2015 -
Company Name
Novan Therapeutics -
Mailing Address
4222 Emperor Boulevard Durham, NC 27703 USA -
Company Description
Novan uses a licensed nitric oxide technology, developed at the lab of Schoenfisch, to give medical devices an antimicrobial coating, helping to fight bacteria. -
Website
http://www.novantherapeutics.com -
Transaction Type
Venture Equity -
Transaction Amount
$50,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
The funds secured will support Novan’s efforts to create impactful, first-in-class, nitric oxide-based healthcare solutions in a number of large market indications. -
M&A Terms
-
Venture Investor
-
Venture Investor
